In this episode of ‘What’s New Doc’ in GU cancer, Prof Emmanuel Seront...
In this episode of ‘What’s New Doc’ in GU cancer, Prof Emmanuel Seront...
How does the NEMIO trial improve neoadjuvant chemotherapy in the perioperative...
The widely recognized enfortumab vedotin (EV), which targets nectin-4, was...
In metastatic renal cell cancer (mRCC), immune checkpoint inhibitors (ICI) are...
In this episode of WND, Prof Emmanuel Seront from UCL Louvain and Prof Vulsteke...
Prof Emmanuel Seront from UCL Louvain and Prof Vulsteke from Maria Middelares...
Professor Emmanuel Seront, medical oncologist at Cliniques Universitaires...
In this episode, Dr Nieves Martinez-Chanza from the Institut Jules Bordet in...
The regimen which combines lenvatinib with pembrolizumab, has become...